SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Frederick Law Olmsted Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientFrederick Law Olmsted
Date of birth1822-04-26
IdentifiersMRN HR-NI022-SYN-TD; SSN (made up) 000-22-5519
Document date2026-11-01
AuthorNathan Calder, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Cognitive evaluation for progressive memory loss: history from patient and caregiver, MoCA, function, mood, safety, and reversible-cause tests. Concerns: He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happening; His caregiver wants to keep him safe at home and needs help and information. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Donepezil 5 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route1895-06-02 to 1895-08-04completedS
Donepezil 10 mg oral tablet, one tablet by mouth each morningOne tablet by mouth each morning with breakfastOral route1895-08-04activeS

Procedures

ProcedureDatesStatusEvidence
MRI of the brain without contrast: generalized cortical atrophy beyond that expected for age, with mild bilateral medial temporal atrophy (MTA score 2) and scattered small white-matter hyperintensities (Fazekas grade 1); no infarct, hemorrhage, mass, or hydrocephalus1895-05-19 to 1895-05-19completedS
Advance care planning conversation with the patient and his caregiver, about 30 minutes1895-08-04 to 1895-08-04completedS

Immunizations

DateVaccineStatusEvidence
1894-10-21High-dose influenza vaccine, 1894-1895 seasoncompletedS
1895-09-15High-dose influenza vaccine, 1895-1896 seasoncompletedS
1895-09-15Pneumococcal conjugate vaccine PCV20completedS
1895-09-15Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1863Exhaustion and illness from overwork while leading a national wartime relief commission, ending in his resignation in 1863; illness not specified in the cited sourceD (CLM-0009)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
He is frustrated that he can no longer keep the details of his projects in mind and wants to understand what is happeningactiveS
His caregiver wants to keep him safe at home and needs help and informationactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.1 on 1895-05-05; Leukocytes [#/volume] in Blood by Automated count 6.2 on 1895-05-05; Platelets [#/volume] in Blood by Automated count 238 on 1895-05-05; Sodium [Moles/volume] in Serum or Plasma 139 on 1895-05-05; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1895-05-05; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 1895-05-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1890)/1.73 sq M 76 on 1895-05-05; Glucose [Mass/volume] in Serum or Plasma 94 on 1895-05-05; Calcium [Mass/volume] in Serum or Plasma 9.4 on 1895-05-05; Albumin [Mass/volume] in Serum or Plasma 4.1 on 1895-05-05; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 on 1895-05-05; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 1895-05-05; Folate [Mass/volume] in Serum or Plasma 12.4 on 1895-05-05; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1895-05-05; Total score [MoCA] 19 on 1895-05-05; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 1895-10-27; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 on 1895-09-15; Total score [AUDIT-C] 0 on 1895-09-15; Cholesterol [Mass/volume] in Serum or Plasma 196 on 1895-09-15; Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 on 1895-09-15; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 on 1895-09-15; Triglyceride [Mass/volume] in Serum or Plasma 120 on 1895-09-15 [S]

Strengths and supports: Supports: his primary caregiver, family at home, long-time colleagues who visit, and a lifelong love of gardens and walking [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Mild dementia (major neurocognitive disorder), progressive, amnestic-predominant with executive difficulty, type undetermined; CDR global 1activeconfirmed F03.A0S — Synthetic modern coding of his documented failing memory; the cause is unknown, so the type is left unspecified. Stage and scores are synthetic.
Common cold, with two nights of increased confusion after an over-the-counter nighttime cold medicine containing diphenhydramine; resolvedresolvedconfirmed J00S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.
Progressive memory loss over about two years with decline in managing his work and affairs, under evaluation for dementia or mild cognitive impairmentresolvedconfirmed R41.3S — Synthetic presenting concern at the index visit, superseded by the dementia diagnosis at the four-week visit; the failing memory is documented (D).

Results

DateMeasureValueUnitReference rangeFlagProvenance
1895-05-05Hemoglobin [Mass/volume] in Blood14.1g/dL13.2-16.6 g/dLNormalS
1895-05-05Leukocytes [#/volume] in Blood by Automated count6.210*3/uL3.4-9.6 10*3/uLNormalS
1895-05-05Platelets [#/volume] in Blood by Automated count23810*3/uL135-317 10*3/uLNormalS
1895-05-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1895-05-05Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.1 mmol/LNormalS
1895-05-05Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
1895-05-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1890)/1.73 sq M76mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1895-05-05Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1895-05-05Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
1895-05-05Albumin [Mass/volume] in Serum or Plasma4.1g/dL3.5-5 g/dLNormalS
1895-05-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L7-55 U/LNormalS
1895-05-05Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
1895-05-05Folate [Mass/volume] in Serum or Plasma12.4ng/mL>=5.9 ng/mLNormalS
1895-05-05Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
1895-05-05Total score [MoCA]19{score}S
1895-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1895-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1895-09-15Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1895-09-15Total score [AUDIT-C]0{score}S
1895-09-15Cholesterol [Mass/volume] in Serum or Plasma196mg/dL<=200 mg/dLNormalS
1895-09-15Cholesterol in HDL [Mass/volume] in Serum or Plasma54mg/dL>=40 mg/dLNormalS
1895-09-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation118mg/dL<=129 mg/dLNormalS
1895-09-15Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1895-05-05Body height175cmS
1895-05-05Body weight72kgS
1895-05-05Body mass index (BMI) [Ratio]23.5kg/m2S
1895-05-05Systolic blood pressure134mm[Hg]S
1895-05-05Diastolic blood pressure78mm[Hg]S
1895-05-05Heart rate72/minS
1895-05-05Respiratory rate14/minS
1895-05-05Body temperature36.7CelS
1895-05-05Oxygen saturation in Arterial blood by Pulse oximetry97%S
1895-06-02Body height175cmS
1895-06-02Body weight71.8kgS
1895-06-02Body mass index (BMI) [Ratio]23.4kg/m2S
1895-06-02Systolic blood pressure132mm[Hg]S
1895-06-02Diastolic blood pressure76mm[Hg]S
1895-06-02Heart rate70/minS
1895-06-02Respiratory rate14/minS
1895-06-02Body temperature36.6CelS
1895-06-02Oxygen saturation in Arterial blood by Pulse oximetry97%S
1895-08-04Body height175cmS
1895-08-04Body weight71.2kgS
1895-08-04Body mass index (BMI) [Ratio]23.2kg/m2S
1895-08-04Systolic blood pressure128mm[Hg]S
1895-08-04Diastolic blood pressure76mm[Hg]S
1895-08-04Heart rate62/minS
1895-08-04Respiratory rate14/minS
1895-08-04Body temperature36.6CelS
1895-08-04Oxygen saturation in Arterial blood by Pulse oximetry97%S
1895-10-27Body height175cmS
1895-10-27Body weight71kgS
1895-10-27Body mass index (BMI) [Ratio]23.2kg/m2S
1895-10-27Systolic blood pressure130mm[Hg]S
1895-10-27Diastolic blood pressure76mm[Hg]S
1895-10-27Heart rate60/minS
1895-10-27Respiratory rate14/minS
1895-10-27Body temperature36.6CelS
1895-10-27Oxygen saturation in Arterial blood by Pulse oximetry97%S
1895-07-14Body height175cmS
1895-07-14Body weight71.4kgS
1895-07-14Body mass index (BMI) [Ratio]23.3kg/m2S
1895-07-14Systolic blood pressure130mm[Hg]S
1895-07-14Diastolic blood pressure74mm[Hg]S
1895-07-14Heart rate70/minS
1895-07-14Respiratory rate16/minS
1895-07-14Body temperature37.4CelS
1895-07-14Oxygen saturation in Arterial blood by Pulse oximetry97%S
1895-09-15Body height175cmS
1895-09-15Body weight71kgS
1895-09-15Body mass index (BMI) [Ratio]23.2kg/m2S
1895-09-15Systolic blood pressure128mm[Hg]S
1895-09-15Diastolic blood pressure74mm[Hg]S
1895-09-15Heart rate60/minS
1895-09-15Respiratory rate14/minS
1895-09-15Body temperature36.6CelS
1895-09-15Oxygen saturation in Arterial blood by Pulse oximetry97%S

Encounters

DatePurposeStatusProvenance
1895-05-05Cognitive evaluation for progressive memory loss: history from patient and caregiver, MoCA, function, mood, safety, and reversible-cause testsfinishedS
1895-06-02Four-week follow-up: results and MRI review, diagnosis disclosure, and behavioral neurology consultationfinishedS
1895-08-04Three-month dementia review: donepezil, safety plan, caregiver burden, and advance care planningfinishedS
1895-10-27Six-month dementia reviewfinishedS
1895-07-14Same-day sick visit for a head cold with night-time confusionfinishedS
1895-09-15Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Reversible-cause tests (blood count, metabolic panel, vitamin B12, folate, TSH) and one non-contrast brain MRI; syphilis and HIV testing only with risk factors or atypical featurescompletedGL-AAN-DEM-2001, GL-ALZ-PC-2025, GL-CMID-2026S
Behavioral neurology consultation to confirm the diagnosis, consider the type and biomarker testing, and advise on treatment and drivingcompletedGL-ALZ-SC-2025, GL-AAN-DEM-2001, GL-AAN-DRIVE-2010S
Donepezil trial, 5 mg daily for four to eight weeks then 10 mg, with heart rate, fainting, gastrointestinal effects, weight, and sleep checked at each visit; avoid anticholinergic drugs, first-generation antihistamines, benzodiazepines, and sleeping pills (AGS Beers Criteria)completedGL-CMID-2026, GL-BEERS-2023S
Safety: stop driving at CDR 1, keep the home free of firearms, medical identification for wandering, supervised medicines and finances, and home safetycompletedGL-AAN-DRIVE-2010, GL-CMID-2026S
Caregiver support: Zarit Burden Interview at diagnosis and every six to twelve months, education, adult day program and respite, and Alzheimer's Association support servicescompletedGL-CMID-2026, GL-ALZ-PC-2025S
Monitor on the CMID dementia schedule: medication review and neuropsychiatric screen at every visit; MoCA, ADL and IADL, CDR or FAST stage, depression screen, fall risk, driving, and advance care planning yearly; repeat tests or imaging only with a sudden changecompletedGL-CMID-2026S
Advance care planning while he can take part: name a health care agent and record his values and wishescompletedGL-CMID-2026, GL-ALZ-PC-2025S

Goals

GoalTargetStatusOutcomeProvenance
Complete the reversible-cause tests and brain MRI and discuss the diagnosis with him and his caregiver by the four-week visit1895-06-02completedTests and MRI showed no reversible cause; diagnosis of mild dementia of undetermined type discussed with bothS
A safety plan in place by the three-month review: no driving, medicines supervised, finances overseen, and medical identification worn1895-08-04completedStopped driving after the consultation; caregiver gives medicines from a weekly organizer and oversees bill paying with his agreement; medical identification bracelet wornS
Donepezil at 10 mg daily without side effects and with resting heart rate 55 or above by the six-month review1895-10-27completedOn 10 mg for three months; heart rate 60; no nausea, diarrhea, weight loss, or vivid dreamsS
Caregiver burden assessed and support in place by the six-month review1895-10-27completedZarit Burden Interview 24 at three months; caregiver education program completed and two days a week of adult day program begunS
Name a health care agent and record his values and wishes while he can take full part, by the three-month review1895-08-04completedHealth care agent named and his wishes recorded at the three-month reviewS

Functional Status

Mental Status